HPC
SILK

HM Payson & Co’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

HM Payson & Co’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8
Closed -$1K – 1203
2020
Q4 		$1K Sell
8
-2
-20% -$124 ﹤0.01% 1073
2020
Q3 		$1K Buy
+10
New +$546 ﹤0.01% 1019

Other funds holding SILK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HM Payson & Co's SILK Position: Q1 2021 in Review

HM Payson & Co sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2021, closing a stake of 8 shares — an estimated $1K sold.

HM Payson & Co first reported a position in SILK in Q3 2020 and held it in 2 quarters. The position peaked at $1K in Q4 2020. 172 funds tracked by Wall St. Rank hold SILK as of Q1 2021.

  • HM Payson & Co reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • HM Payson & Co sold 8 Silk Road Medical, Inc. Common Stock shares in Q1 2021, an estimated $1K.
  • HM Payson & Co first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • HM Payson & Co's Silk Road Medical, Inc. Common Stock position peaked at $1K in Q4 2020.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2021.

Based on HM Payson & Co's 13F filing for Q1 2021, filed 15 Jun 2021.